Puma Biotechnology (PBYI) EBIT (2010 - 2026)
Puma Biotechnology (PBYI) recorded EBIT of $7.59 million in Q2 2026, up 14.3% from $6.64 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Puma Biotechnology's EBIT came in at $30.44 million as of Jun 30, 2026, down 33.9% year-over-year; for FY2025, it was $37.3 million, up 20.5% from FY2024.
- Across earlier years, EBIT came in at $30.97 million in FY2024 (-5.1%), $32.64 million in FY2023 (+37.6%), $23.72 million in FY2022 and $1.29 million in FY2021.
- Quarterly EBIT has ranged from -$8.95 million in Q3 2021 to $22.08 million in Q3 2024 over the past five years.
- On a year-over-year basis, EBIT rose in three of the last five quarters, with growth averaging 26.6%.
- Peak year-over-year performance for EBIT in the last five years was growth of 258.8% in Q3 2023, against a decline of 59.4% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$3.83 million (Q1 2026), $17.11 million (Q4 2025) and $9.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 7.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.59 Mn |
| Mar 31, 2026 | -3.83 Mn |
| Dec 31, 2025 | 17.11 Mn |
| Sep 30, 2025 | 9.57 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 13.37 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 2.39 Mn |
| Jun 30, 2022 | 12.06 Mn |
| Mar 31, 2022 | -747,000.00 |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2021 | -8.95 Mn |
API Access
Puma Biotechnology EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();